Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin

Breast Cancer Research and Treatment

Volumn 14, Issue 3, 1989, Pages 307-314

  Szende, Bela ^a,b   Lapis, Karoly ^a,b,c   Redding, Tommie W ^a,b   Srkalovic, Gordan ^a,b   Schally, Andrew V ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

apoptosis; D Trp 6 LH RH; luteinizing hormone releasing hormone (LH RH); MXT mammary tumor; programmed cell death; somatostatin analog RC 160

Indexed keywords

TRIPTORELIN; VAPREOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BREAST CARCINOMA; FEMALE; GROWTH INHIBITION; MOUSE; NONHUMAN;

ADENOCARCINOMA; ANIMAL; CELL SURVIVAL; FEMALE; GONADORELIN; LUTEINIZING HORMONE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED STRAINS; ORGAN WEIGHT; OVARY; RADIOLIGAND ASSAY; SOMATOSTATIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; UTERUS;

EID: 0024830886     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF01806302     Document Type: Article

References (30)

1. Use of Luteinizing Hormone-Releasing Hormone analogs in the treatment of hormone dependent tumors
2. Oncological applications of somatostatin analogs
3. Analogs of LH-RH. The present and the future
4. Response of advanced adenocarcinoma of pancreas to D-Trp-6-LH-RH
5. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer
6. Membrane receptors for peptides in experimental and human pancreatic cancers
7. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
8. Antiproliferative effects of somatostatin analogs SMS 201-995 on three human breast cancer cell lines
9. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells
10. The regression process in hormone-dependent mammary carcinomas
11. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin
12. Estrogen receptor characterization in a transplantable mouse mammary tumor
13. Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH
14. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp-6-LH-RH
15. Inhibition of growth of the transplantable rat chondrosarcoma by analogs of hypothalamic hormones
16. Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones
17. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone
18. Mammary tumor regression, I. Physiopathologic characteristics of hormone-dependent tissue
19. Mammary tumor regression, II. Autophagy of neoplastic cells
20. Apoptosis: basic biological phenomenon with wide-ranging implications in tissue kinetics
21. An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells
22. The biology of cell death in tumors
23. What is apoptosis?
24. The effects of long-term feeding of soybean flour diets on pancreatic growth in the rat
25. Pancreatic blood flow in the rat during enlargement, involution and cholecystokinin treatment
26. Cell death (apoptosis) during pancreatic involution after raw soya flour feeding in the rat
27. Cell proliferation studies in the rat prostate: II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation